CCS
LRCX icon

Concentric Capital Strategies’s Lam Research LRCX Stock Holding History

Concentric Capital Strategies’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.45M Buy
19,506
+17,971
+1,171% +$5.46M 0.47% 27
2026
Q1 		$328K Sell
1,535
-100,225
-98% -$22.4M 0.03% 265
2025
Q4 		$17.4M Buy
+101,760
New +$15.8M 0.84% 18
2025
Q3 		– Sell
-30,298
Closed -$2.95M – 368
2025
Q2 		$2.95M Sell
30,298
-18,473
-38% -$1.47M 0.13% 157
2025
Q1 		$3.55M Sell
48,771
-135,910
-74% -$10.7M 0.33% 54
2024
Q4 		$13.3M Buy
+184,681
New +$14M 0.61% 29
2024
Q3 		– Sell
-23,490
Closed -$2.5M – 338
2024
Q2 		$2.5M Sell
23,490
-10,870
-32% -$1.04M 0.13% 173
2024
Q1 		$3.34M Buy
+34,360
New +$3.02M 0.19% 131
2023
Q4 		– Sell
-6,110
Closed -$383K – 281
2023
Q3 		$383K Buy
+6,110
New +$401K 0.04% 190

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concentric Capital Strategies's LRCX Position: Q2 2026 in Review

Concentric Capital Strategies increased its Lam Research (LRCX) stake by 1,171% in Q2 2026, buying an estimated $5.46M and bringing the position to 19,506 shares worth $8.45M. The position accounts for 0.47% of the portfolio, ranked #27.

Concentric Capital Strategies first reported a position in LRCX in Q3 2023 and has held it in 9 quarters since. The position peaked at $17.4M in Q4 2025. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Concentric Capital Strategies held 19,506 shares of Lam Research worth $8.45M as of Q2 2026.
  • Concentric Capital Strategies bought 17,971 Lam Research shares in Q2 2026, an estimated $5.46M.
  • Lam Research made up 0.47% of Concentric Capital Strategies's portfolio in Q2 2026, its #27 holding.
  • Concentric Capital Strategies first reported a position in Lam Research in Q3 2023 and has held it in 9 quarters since.
  • Concentric Capital Strategies's Lam Research position peaked at $17.4M in Q4 2025.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.